Business

Announcement on Subsidiary Xinchang Pharmaceutical Factory Passing On-site Inspection by FDA of the United States

Announcement on Subsidiary Xinchang Pharmaceutical Factory Passing On-site Inspection by FDA of the United States

articleZhejiang Medicine Co., Ltd. Class AJune 9, 20254/news/announcement-on-subsidiary-xinchang-pharmaceutical-factory-passing-on-site-inspection-by-fda-of-the-united-states
Announcement on Subsidiary Xinchang Pharmaceutical Factory Passing On-site Inspection by FDA of the United States

About this update from Zhejiang Medicine Co., Ltd. Class A

Announcement on Subsidiary Xinchang Pharmaceutical Factory Passing On-site Inspection by FDA of the United StatesThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Zhejiang Medicine Co., Ltd. Class A